Literature DB >> 27681311

Short-term treatment of equine wounds with orf virus IL-10 and VEGF-E dampens inflammation and promotes repair processes without accelerating closure.

Christa J Bodaan1, Lyn M Wise2, Kirsty A Wakelin2, Gabriella S Stuart2, Nicola C Real2, Andrew A Mercer2, Christopher B Riley1, Christine Theoret1,3.   

Abstract

Healing is delayed in limb wounds relative to body wounds of horses, partly because of sustained inflammation and inefficient angiogenesis. In laboratory animals, proteins derived from orf virus modulate these processes and enhance healing. We aimed to compare immune cell trafficking and the inflammatory, vascular, and epidermal responses in body and limb wounds of horses and then to investigate the impact of orf virus interleukin-10 and vascular endothelial growth factor-E on these processes. Standardized excisional wounds were created on the body and forelimb of horses and their progression monitored macroscopically until healed. Tissue samples were harvested to measure the expression of genes regulating inflammation and repair (quantitative polymerase chain reaction) and to observe epithelialization (histology), innate immune cell infiltration, and angiogenesis (immunofluorescence). Delayed healing of limb wounds was characterized by intensified and extended pro-inflammatory signaling and exacerbated innate immune response, concomitant with the absence of anti-inflammatory eIL-10. Blood vessels were initially more permeable and then matured belatedly, concomitant with retarded production of angiogenic factors. Epithelial coverage was achieved belatedly in limb wounds. Viral proteins were administered to wounds of one body and one limb site/horse at days 1-3, while wounds at matching sites served as controls. Treatment dampened pro-inflammatory gene expression and the innate immune response in all wounds. It also improved angiogenic gene expression, but primarily in body wounds, where it altered blood vessel density and myofibroblast persistence. Moreover, the viral proteins increased epithelialization of all wounds. The short-term viral protein therapy did not, however, improve the healing rate of wounds in either location, likely due to suboptimal dosing. In conclusion, we have further detailed the processes contributing to protracted healing in limb wounds of horses and shown that short-term administration of viral proteins exerts several promising though transient effects that, if optimized, may positively influence healing.
© 2016 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27681311     DOI: 10.1111/wrr.12488

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  9 in total

1.  VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury.

Authors:  Lyn M Wise; Gabriella S Stuart; Nicola C Real; Stephen B Fleming; Andrew A Mercer
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-08-01       Impact factor: 4.730

2.  Use of next generation sequencing to investigate the microbiota of experimentally induced wounds and the effect of bandaging in horses.

Authors:  Louis J Kamus; Christine Theoret; Marcio C Costa
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

3.  Orf virus (ORFV) infection in a three-dimensional human skin model: Characteristic cellular alterations and interference with keratinocyte differentiation.

Authors:  Mahmod Muhsen; Martina Protschka; Laura E Schneider; Uwe Müller; Gabriele Köhler; Thomas M Magin; Mathias Büttner; Gottfried Alber; Sabine Siegemund
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

4.  Functional Inhibition of Natural Killer Cells in a BALB/c Mouse Model of Liver Fibrosis Induced by Schistosoma japonicum Infection.

Authors:  Yuan Hu; Xiaoling Wang; Yuhuan Wei; Hua Liu; Jing Zhang; Yujuan Shen; Jianping Cao
Journal:  Front Cell Infect Microbiol       Date:  2020-11-19       Impact factor: 5.293

5.  Treatment of limb wounds of horses with orf virus IL-10 and VEGF-E accelerates resolution of exuberant granulation tissue, but does not prevent its development.

Authors:  Lyn M Wise; Christa J Bodaan; Gabriella S Stuart; Nicola C Real; Zabeen Lateef; Andrew A Mercer; Christopher B Riley; Christine L Theoret
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

Review 6.  VEGF Upregulation in Viral Infections and Its Possible Therapeutic Implications.

Authors:  Khaled R Alkharsah
Journal:  Int J Mol Sci       Date:  2018-06-01       Impact factor: 5.923

7.  Orf Virus IL-10 and VEGF-E Act Synergistically to Enhance Healing of Cutaneous Wounds in Mice.

Authors:  Lyn M Wise; Gabriella S Stuart; Nicola C Jones; Stephen B Fleming; Andrew A Mercer
Journal:  J Clin Med       Date:  2020-04-11       Impact factor: 4.241

Review 8.  Deriving Immune Modulating Drugs from Viruses-A New Class of Biologics.

Authors:  Jordan R Yaron; Liqiang Zhang; Qiuyun Guo; Michelle Burgin; Lauren N Schutz; Enkidia Awo; Lyn Wise; Kurt L Krause; Cristhian J Ildefonso; Jacek M Kwiecien; Michael Juby; Masmudur M Rahman; Hao Chen; Richard W Moyer; Antonio Alcami; Grant McFadden; Alexandra R Lucas
Journal:  J Clin Med       Date:  2020-03-31       Impact factor: 4.241

9.  Anti-fibrotic Actions of Equine Interleukin-10 on Transforming Growth Factor-Beta1-Stimulated Dermal Fibroblasts Isolated From Limbs of Horses.

Authors:  Lyn M Wise; Gabriella S Stuart; Kevalee Sriutaisuk; Brooke R Adams; Christopher B Riley; Christine L Theoret
Journal:  Front Vet Sci       Date:  2020-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.